Vaccines Receive FDA Orphan Drug Designation For Advanced Head And Neck Cancer
The Food and Drug Administration recently gave a federal orphan drug designation to two experimental vaccines from the University of Maryland, Baltimore (UMB) for advanced head and neck cancer, according to Medical News Net reports this week. Orphan status for the vaccines means tax credits and marketing incentives from the FDA; the vaccines were eligible because they were personalized for a limited number of patients.
Vaccines such as these are designed precisely to boost the immune system. They contain certain compounds that act as biological recognition points for specific substances associated with some head and neck cancerous tumors. Our bodies are most likely forming early cancer cells all the time, however, our immune system addresses them and at times kills tumor cells before they become malignant. When the immune system cannot overcome the tumors, they begin to grow and eventually metastasize (spread throughout our system) and cancers in large glands in the head may require Beverly Hills parotid gland surgery to minimize damage to surrounding healthy cells. Los Angeles Parotid surgery procedures and other surgical operations become sometimes necessary as the effective use of vaccines largely depends on patients’ genetic disposition and other factors.
Advanced head and neck cancer remains a challenging disease with limited treatment options. Even with chemotherapy, radiation, and surgery, people with advanced head and neck cancers like mouth and Los Angeles salivary gland cancer may have a limited life expectancy of half a year to eight months. Some head and neck cancer surgeons have observed that the survival of head and neck cancer patients has not significantly improved in 30 years.
Beverly Hills Head and neck cancer is different from brain cancers in that it includes cancers of the tongue, tonsils, nasal cavity, sinuses, lips, mouth, salivary glands, throat, and larynx. For more than two decades, medical researchers have pursued cancer therapeutic vaccines against tumors, and many experts believe new vaccines have a reasonable chance to help some patients where others have failed.
Disclaimer: This blog is for information purpose only, and should not be treated a professional advise or price protection guarantee. This blog is mainly used to help our customers blog their information to the readers who may find articles listed on this blog interesting, Intact Info Solutions may also use this blog for commercial purpose or for higher search engine ranking via SEO-search engine optimization or website optimization - web 2.0 search technology. It is advised that readers seek professional consultation in the field of interest for more information.
